tradmap

IBAC IB Acquisition Corp.

$10.83 -0.69%

Data as of close

Industrials · Services-Commercial Physical & Biological Research

IB Acquisition Corp. (IBAC) is an industrial company in the Services-Commercial Physical & Biological Research industry, with a market capitalization of $54 million. Shares last traded at $10.83, 6.8% below their 52-week high.

Market Cap
$54M
Shares Out
5.0M
EPS (TTM)
—
P/E (TTM)*
—
P/S Ratio
—
P/B Ratio
—
Dividend / Share
—
Dividend Yield
—
52-Week High
$11.62
52-Week Low
$10.48
Volume (venue)
310
Avg Vol (3m, venue)
483.683

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
—
1M
—
3M
—
6M
—
YTD
+3.34%
1Y
—

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
48.41
SMA (50)
$10.75
SMA (200)
—
Price vs SMA50
+0.70%
Price vs SMA200
—
ATR (14)
$0.15

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
—
Net Income
-$399569
Gross Margin
—
Operating Margin
—
Net Margin
—
Return on Equity
—
Return on Assets
-4.7%
Current Ratio
0.14
Debt / Equity
—
Revenue Growth (YoY)
—

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Services-Commercial Physical & Biological Research peers

IBAC vs 14 industry peers (Services-Commercial Physical & Biological Research), by market cap. Data as of close

1–14 of 14
IQVIQVIA$43.5B31.182.518.1%+0.45%
INCYIncyte$25.1B62.114.176.7%+4.53%
MEDPMedpace Holdings, Inc.$18.4B35.466.4718.2%-1.08%
CRLCharles River Laboratories$15.6B389.093.931.0%-7.16%
ABSIAbsci Corp$1.8B—1154.35—+5.00%
OABIOmniAb, Inc.$755M———+0.39%
NRCNrc Health$574M49.443.998.4%+12.30%
MXCTMAXCYTE, INC.$142M———-4.83%
IBACIB Acquisition Corp.$54M———-0.69%
ONMDOneMedNet Corp$27M———+6.03%
ISPCiSpecimen Inc.$2M———+7.67%
BIAFbioAffinity Technologies, Inc.$2M———-2.58%
IBACRIB Acquisition Corp.————+1.32%
ICLRIcon Plc———5.4%-0.33%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.